Health Sciences Program, School of Health Sciences, Western Carolina University, Cullowhee, NC, USA.
Department of Research Programs, Fort Belvoir Community Hospital, Fort Belvoir, VA.
J Addict Dis. 2020 Jul-Sep;38(3):271-279. doi: 10.1080/10550887.2020.1751023. Epub 2020 Apr 14.
: The opioid epidemic's impact reached an increasing portion of the United States population, including pregnant women.: We sought to determine the prevalence and factors associated with opioid use disorders during pregnancy in North Carolina.: Using North Carolina's State Inpatient Sample, a retrospective study was conducted to identify pregnancy-related discharges between 2000 and 2014. Hospital discharge records associated with ICD-9-CM diagnoses codes for the use of opioids for all eligible pregnancy-related discharges were extracted. Logistic regression models were used to estimate unadjusted and adjusted bivariate and multivariate relationships.: Of 1,937,455 pregnancy-related hospitalization in North Carolina, 6,084 were associated with opioid use, a prevalence of 3.14 cases per 1,000 discharge. Maternal opioid use was associated with an increased odds of early onset delivery, threatened preterm labor, premature rupture of membranes, postpartum depression, stillbirth and poor fetal growth. Women who used opioids during pregnancy had prolonged hospital stays (>5 days) and were 2 times as likely to have more than 4 procedures performed during hospitalization. Compared to other racial groups, non-Hispanic whites had a notably higher prevalence of opioid use disorders (5.8/1,000 pregnancy-related discharges) ().: Very few health issues have garnered the attention of such diverse sectors of our society as the opioid epidemic. As the first state-level analysis of opioid use disorders among delivery hospitalizations, these findings suggest the need for a system-wide public health response such as improved funding for Medicaid and child welfare systems to improve the health of the opioid-exposed mother-infant dyad.
美国越来越多的人群受到阿片类药物流行的影响,包括孕妇。我们试图确定北卡罗来纳州孕妇阿片类药物使用障碍的流行率和相关因素。利用北卡罗来纳州的州住院患者样本,进行了一项回顾性研究,以确定 2000 年至 2014 年期间与妊娠相关的出院情况。提取与所有符合条件的妊娠相关出院病例中使用阿片类药物相关的 ICD-9-CM 诊断代码的医院出院记录。使用逻辑回归模型来估计未调整和调整的双变量和多变量关系。在北卡罗来纳州 1937455 例与妊娠相关的住院治疗中,有 6084 例与阿片类药物使用有关,流行率为每 1000 例出院 3.14 例。产妇阿片类药物使用与早产、早产威胁、胎膜早破、产后抑郁症、死产和胎儿生长不良的发生几率增加有关。在怀孕期间使用阿片类药物的女性住院时间延长(>5 天),并且在住院期间进行的手术次数超过 4 次的可能性是其他种族群体的两倍。与其他种族群体相比,非西班牙裔白人的阿片类药物使用障碍的流行率明显更高(每 1000 例妊娠相关出院 5.8 例)。几乎没有任何健康问题能像阿片类药物流行这样引起我们社会如此多样化的部门的关注。作为对分娩住院患者阿片类药物使用障碍的首次州级分析,这些发现表明需要进行系统范围的公共卫生应对,例如增加医疗补助和儿童福利系统的资金,以改善阿片类药物暴露的母婴对的健康状况。